Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Gene expression profiling after vaccination with the RTS,S candidate malaria vaccine in a controlled human malaria infection study


ABSTRACT: RTS,S is the sole candidate vaccine shown to provide protection against infection to malaria-naive adults challenged with mosquito-borne homologous falciparum malaria and protection against infection and clinical and severe disease to volunteers in malaria-endemic Africa who were exposed to diverse Plasmodium falciparum strains. In this experiment we profiled gene expression in PBMCs after vaccination with the RTS,S candidate malaria vaccine in a controlled human malaria infection study. Subjects were vaccinated with three doses of the RTS,S candidate malaria vaccine. Blood samples for PBMC isolation and subsequent gene expression analysis were taken on day 0 (0m), day of the third vaccination (8w), 1 day post third vaccination (8w1d), 3 days post third vaccination (8w3d), the day of the infection (10w), 1 day post infection (10w1d), and 5 days post infection (10w5d). After infection the subjects were closely monitored for parasitemia. The response to the controlled infection was recorded as follows: no parasitemia (P, protected), parasitemia in the same time frame as the control group (NP, not protected), parasitemia later than the control group (DL, delayed). In addition to the experimental factors, a confounding factor was identified in the data analysis related to the use of a specific kit batch (Kit A or B).

ORGANISM(S): Homo sapiens

SUBMITTER: Robert van den Berg 

PROVIDER: E-MTAB-4629 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.

Kester Kent E KE   Cummings James F JF   Ofori-Anyinam Opokua O   Ockenhouse Christian F CF   Krzych Urszula U   Moris Philippe P   Schwenk Robert R   Nielsen Robin A RA   Debebe Zufan Z   Pinelis Evgeny E   Juompan Laure L   Williams Jack J   Dowler Megan M   Stewart V Ann VA   Wirtz Robert A RA   Dubois Marie-Claude MC   Lievens Marc M   Cohen Joe J   Ballou W Ripley WR   Heppner D Gray DG  

The Journal of infectious diseases 20090801 3


<h4>Background</h4>To further increase the efficacy of malaria vaccine RTS,S/AS02A, we tested the RTS,S antigen formulated using the AS01B Adjuvant System (GlaxoSmithKline Biologicals).<h4>Methods</h4>In a double-blind, randomized trial, 102 healthy volunteers were evenly allocated to receive RTS,S/AS01B or RTS,S/AS02A vaccine at months 0, 1, and 2 of the study, followed by malaria challenge. Protected vaccine recipients were rechallenged 5 months later.<h4>Results</h4>RTS,S/AS01B and RTS,S/AS02  ...[more]

Similar Datasets

2020-09-01 | GSE103862 | GEO
2020-09-01 | GSE103874 | GEO
2020-04-21 | GSE107672 | GEO
2021-06-05 | GSE176156 | GEO
2012-02-15 | E-GEOD-35816 | biostudies-arrayexpress
2010-06-25 | E-GEOD-13202 | biostudies-arrayexpress
2020-04-21 | GSE102288 | GEO
2012-09-28 | E-GEOD-40719 | biostudies-arrayexpress
2020-05-13 | GSE144826 | GEO
2018-08-30 | E-MTAB-6574 | biostudies-arrayexpress